Characterization of interferon induced in murine macrophage cultures by 10-carboxymethyl-9-acridanoneBREHM, G; STORCH, E; KIRCHNER, H et al.Natural immunity and cell growth regulation. 1986, Vol 5, Num 1, pp 50-59, issn 0254-7600Article

Evaluation of the in vitro production of interferon γ and other lymphokines in uremic patientsYOUSEFI, S; VAZIRI, N. D; CARANDANG, G et al.Proceedings of the Society for Experimental Biology and Medicine. 1987, Vol 184, Num 2, pp 179-185, issn 0037-9727Article

Synthesis and biological properties of chimeric interferon-α2b peptidesPENA, Clara; BLANK, Viviana C; MARINO, Veronica J et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 7, pp 1144-1149, issn 0196-9781, 6 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α_2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Factor determining the antigenic type of interferons produced in human lymphoblastoid cell linesMATSUOKA, H; IMANISHI, J; HOSHINO, S et al.Biken journal. 1984, Vol 27, Num 4, pp 153-159, issn 0006-2324Article

Medizinische und kommerzielle Aspekte der menschlichen Interferone = Aspects médicaux et commerciaux des interférons humains = Medical and commercial aspects of human interferonsVON EICHBORN, J. F.Arzneimittel-Forschung. 1986, Vol 36, Num 2, pp 279-282, issn 0004-4172Article

Assay of interferonsFORTI, R. L; SCHUFFMAN, S. S; FLEISCHMANN, W. R. JR et al.Methods in enzymology. 1986, Vol 119, pp 533-593, issn 0076-6879Article

Purifications of interferonsTARNOWSKI, S. J; ROY, S. K; CHIEN-HWA CHEN et al.TARNOWSKI, S. J; Methods in enzymology. 1986, Vol 119, pp 153-230, issn 0076-6879Article

Current view on the perspectives of interferon therapyBORECKY, C.Acta virologica (English ed.). 1986, Vol 30, Num 2, pp 161-169, issn 0001-723XArticle

Radiolabeling of interferonsSARKAR, F. H; GUPTA, S. L; PESTKA, S et al.Methods in enzymology. 1986, Vol 119, pp 263-301, issn 0076-6879Article

Inductions of interferons. A: Human interferons. ― B: Non-human interferonsKAUPPINEN, H.-L; HIRVONEN, S; YIP, Y. K et al.Methods in enzymology. 1986, Vol 119, pp 27-149, issn 0076-6879Article

Interferons : The pathways of discovery. II. Immunomodulatory, In vivo and applied aspectsBILLIAU, Alfons.Journal of clinical virology. 2007, Vol 39, Num 4, pp 241-265, issn 1386-6532, 25 p.Article

Interferons: what future?SCOTT, G. M.Trends in biotechnology (Library edition). 1986, Vol 4, Num 4, pp 78-79, issn 0167-9430Article

The clinical use of interferonsRINGENBERG, Q. S; ANDERSON, P. C.International journal of dermatology. 1986, Vol 25, Num 5, issn 0011-9059, 294Article

Interferon treatment of human neoplasiaSTRANDER, H.Advances in cancer research. 1986, Vol 46, issn 0065-230X, X-265 pSerial Issue

The physiological interferon response. IV: Production of interferon by the perfused human placenta at termBOCCI, V; PAULESU, L; RICCI, M. G et al.Proceedings of the Society for Experimental Biology and Medicine. 1985, Vol 180, Num 1, pp 137-143, issn 0037-9727Article

Simulation mathématique de l'influence des inducteurs d'interféron sur le développement des infections viralesCHIZHOV, N. P; CHRUNOSOV, E. V.Voprosy virusologii. 1988, Vol 33, Num 1, pp 94-98, issn 0507-4088Article

Current status of recombinant interferon in cancer therapy, congress, Los Angeles CA May 3, 1986Cancer. 1987, Vol 59, Num 3, pp 633-674, issn 0008-543X, suppl. 2Conference Proceedings

Interferon enhanced natural killer function in Hodgkin's diseaseLEVY, S; REINS, F; ALEKSIJEVIC, A et al.Nouvelle revue française d'hématologie. 1986, Vol 28, Num 5, pp 323-325, issn 0029-4810Article

Modification and analysis of interferonsFANTES, K. H; FELIX, A. M; HEIMER, E. P et al.Methods in enzymology. 1986, Vol 119, pp 233-260, issn 0076-6879Article

Activated interferon system in healthy homosexual menLEVIN, S; HAHN, T; BENTWICH, Z et al.Antiviral research. 1985, Vol 5, Num 4, pp 229-240, issn 0166-3542Article

Determination of human interferons α,β and γ in plasma and/or pharmaceuticalsNAITO, S.-I; TANAKA, S; MIZUMO, M et al.International journal of pharmaceutics. 1983, Vol 17, Num 1, pp 109-114, issn 0378-5173Article

Immunogenicity of biopharmaceuticals. The european perspectiveSCHELLEKENS, H; CASADEVALL, N.Developments in biologicals. 2003, Vol 112, pp 23-28, issn 1424-6074, 6 p.Article

Interférons et maladies auto-immunes = Interferons and autoimmune disordersMEYER, Olivier.Revue du rhumatisme (Ed. française). 2009, Vol 76, Num 9, pp 833-842, issn 1169-8330, 10 p.Article

Novel delivery systems for interferonsHAMIDI, Mehrdad; ZARRIN, Abdolhossein; FOROOZESH, Mahshid et al.Critical reviews in biotechnology. 2007, Vol 27, Num 3, pp 111-127, issn 0738-8551, 17 p.Article